Citalopram Combined with Behavioral Therapy Reduces Cocaine Use: A Double-Blind, Placebo-Controlled Trial

REFERENCES

• Burmeister JJ, Lungren EM, Neisewander JL. Effects of fluoxetine and d-fenfluramine on cocaine-seeking behavior in rats. Psychopharmacology (Berl) 2003; 168:136–154.
   Web of Science ®Google Scholar
• Filip M, Cunningham KA. Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex. J Pharmacology Experimental Therapeutics 2003; 306:734–743.
   PubMed Web of Science ®Google Scholar
• Carroll ME, Lac ST, Asencio M, Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 1990; 35:237–244.
   PubMed Web of Science ®Google Scholar
• Peltier R, Schenk S. Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology 1993; 110:390–394.
   PubMed Web of Science ®Google Scholar
• Patkar AA, Gottheil E, Berrettini WH, Thornton CC, Hill KP, Weinstein SP. Relationship between platelet serotonin uptake sites and treatment outcome among African-American cocaine dependent individuals. J Addict Dis 2003; 22:79–92.
   PubMed Web of Science ®Google Scholar
• Batki SL, Washburn AM, Delucchi K, Jones RT. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend 1996; 41:137–142.
   PubMed Web of Science ®Google Scholar
• Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacol 1995; 15:163–174.
   PubMed Web of Science ®Google Scholar
• Covi L, Hess JM, Kreiter NA, Haertzen CA. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995; 21:327–344.
   PubMed Web of Science ®Google Scholar
• Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacol 2003; 168:44–56.
   PubMed Web of Science ®Google Scholar
• Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Foerg F, Fenwick JW. A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry 1991; 148:1218–1224.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Rhoades HM, Elk R, Creson D, Hussein I, Grabowski J. Medication take-home doses and contingency management. Experimental and Clinical Psychopharmacology 1998; 6:162–168.
   PubMed Web of Science ®Google Scholar
• Sayre SL, Evans M, Hokanson PS, Schmitz JM, Stotts AL, Averill P, Grabowski J. “Who gets in?”: Recruitment and screening processes of outpatient substance abuse trials. Addict Behav 2004; 29:389–398.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Higgins ST. A community reinforcement plus vouchers approach: Treating cocaine addiction. Therapy Manuals for Drug Addiction 1998; USDHHS NIH Pub No 98-4309.
   Google Scholar
• Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press, 1985.
   Google Scholar
• Schmitz JM, Oswald LM, Jacks SD, Rustin T, Rhoades HM, Grabowski J. Relapse prevention treatment for cocaine dependence: group vs. individual format. Addict Behav 1997; 22:405–418.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend 2001; 63:207–214.
   PubMed Web of Science ®Google Scholar
• Fekete J, del Castilho P, Kraak JC. Reversed-phase liquid chromatography for the separation of chloropromazine, imipramine, and some of their metabolites. J Chromatogr 1981; 204:319–327.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62.
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychology 1959; 32:50–55.
   PubMed Web of Science ®Google Scholar
• Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Newbury Park, CA: Sage Publications, 2002.
   Google Scholar
• Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006; 63:219–228.
   PubMed Web of Science ®Google Scholar
• Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 2004; 75:233–240.
   PubMed Web of Science ®Google Scholar
• Charlier C, Pinto E, Ansseau M, Plomteux G. Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, paroxetine or venlafaxine. Hum Psychopharmacol 2000; 15:453–459.
   PubMed Web of Science ®Google Scholar
• Jenck F, Moreau JL, Berendsen HH, Boes M, Broekkamp CL, Martin JR, Wichmann J, Van Delft AM. Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. Eur Neuropsychopharmacol 1998; 8:161–168.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Not so selective serotonin reuptake inhibitors. J Clin Psychiatry 1998; 59:343–344.
   PubMed Web of Science ®Google Scholar
• Ni YG, Miledi R. Blockage of 5HT2C receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94:2036–2040.
   PubMed Web of Science ®Google Scholar
• Jenck F, Moreau JL, Berendsen HH, , et al. Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. Eur Neuropsychopharmacol 1998; 8:161–168.
   PubMed Web of Science ®Google Scholar
• Filip M, Nowak E, Papla I. On the role of serotonin 2A/2C receptors in the sensitization to cocaine. J Physiol Pharmacol 2001; 52:471–481.
   PubMed Web of Science ®Google Scholar
• McMahon LR, Cunningham KA. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 2001; 297:357–363.
   PubMed Web of Science ®Google Scholar
• Fletcher PJ, Grottick AJ, Higgins GA. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacol 2002; 27:576–586.
   PubMed Web of Science ®Google Scholar
• Filip M, Bubar MJ, Cunningham KA. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: Acute and chronic pharmacological analyses. J Pharmacol Exp Ther 2004; 310:1246–1254.
   PubMed Web of Science ®Google Scholar
• Fletcher PJ, Sinyard J, Salsali M, Baker GB. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacol (Berl) 2004; 174:406–413.
   PubMed Web of Science ®Google Scholar
• Kampman M, Keijsers GP, Hoogduin CA, Verbraak MJ. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand 2002; 106:314–319.
   PubMed Web of Science ®Google Scholar
• Tenneij NH, van Megen HJ, Denys DA, Westenberg HG. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry 2005; 66:1169–1175.
   PubMed Web of Science ®Google Scholar
• Hohagen F, Winkelmann G, Rasche-Ruchle H, Hand I, Konig A, Munchau N, Hiss H, Geiger-Kabisch C, Kappler C, Schramm P, Rey E, Aldenhoff J, Berger M. Combination fo behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. Br J Psychiatry Suppl 1998; 35: 71–78.
   Google Scholar
• Evans DW, Lewis MD, Lobst E. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder. Brain Cogn 2004; 55:220–234.
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Beckson M, Lu PH, Edwards N, Bridge P, Mintz, J. Brain maturation may be arrested in chronic cocaine addicts. Biol Psychiatry 2002; 51: 605–611.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148: 621–626.
   PubMed Web of Science ®Google Scholar
• Lim, KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP. Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 2002; 51: 890–895.
   PubMed Web of Science ®Google Scholar
• Moeller FG, Hasan KM, Steinberg JL, Kramer LA, Dougherty DM, Santos RM, Valdes I, Swann AC, Barratt ES, Narayana PA. Reduced anterior corpuse callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine dependent subjects: diffusion tensor imaging. Neuropsychopharm 2005; 30: 610–617.
   PubMed Web of Science ®Google Scholar
• Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend 2003; 70: 315–325.
   PubMed Web of Science ®Google Scholar